4-75860903-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PP3_ModerateBS2
The NM_006239.3(PPEF2):c.2026G>A(p.Glu676Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000275 in 1,614,090 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 2 hom. )
Consequence
PPEF2
NM_006239.3 missense
NM_006239.3 missense
Scores
7
11
1
Clinical Significance
Conservation
PhyloP100: 5.70
Genes affected
PPEF2 (HGNC:9244): (protein phosphatase with EF-hand domain 2) This gene encodes a member of the serine/threonine protein phosphatase with EF-hand motif family. The protein contains a protein phosphatase catalytic domain, and at least two EF-hand calcium-binding motifs in its C terminus. Although its substrate(s) is unknown, the encoded protein, which is expressed specifically in photoreceptors and the pineal, has been suggested to play a role in the visual system. This gene shares high sequence similarity with the Drosophila retinal degeneration C (rdgC) gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM1
In a binding_site (size 0) in uniprot entity PPE2_HUMAN
PP3
MetaRNN computational evidence supports a deleterious effect, 0.861
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPEF2 | NM_006239.3 | c.2026G>A | p.Glu676Lys | missense_variant | 17/17 | ENST00000286719.12 | |
PPEF2 | XM_011532039.3 | c.2026G>A | p.Glu676Lys | missense_variant | 16/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPEF2 | ENST00000286719.12 | c.2026G>A | p.Glu676Lys | missense_variant | 17/17 | 1 | NM_006239.3 | P1 | |
PPEF2 | ENST00000511880.7 | c.*2431G>A | 3_prime_UTR_variant, NMD_transcript_variant | 18/18 | 1 | ||||
PPEF2 | ENST00000652700.1 | c.535G>A | p.Glu179Lys | missense_variant | 6/6 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152224Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
31
AN:
152224
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000184 AC: 46AN: 250642Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135536
GnomAD3 exomes
AF:
AC:
46
AN:
250642
Hom.:
AF XY:
AC XY:
29
AN XY:
135536
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000283 AC: 413AN: 1461748Hom.: 2 Cov.: 31 AF XY: 0.000261 AC XY: 190AN XY: 727138
GnomAD4 exome
AF:
AC:
413
AN:
1461748
Hom.:
Cov.:
31
AF XY:
AC XY:
190
AN XY:
727138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000203 AC: 31AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74506
GnomAD4 genome
AF:
AC:
31
AN:
152342
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
20
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2021 | The c.2026G>A (p.E676K) alteration is located in exon 17 (coding exon 16) of the PPEF2 gene. This alteration results from a G to A substitution at nucleotide position 2026, causing the glutamic acid (E) at amino acid position 676 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at